Makers of brand-name drugs increasingly issue coupons that cover patient co-pays while leaving pharmacy benefit managers, insurers and other payers on the hook for high prices. Experts say the practice allows drugmakers to charge high prices for drugs, and the costs are passed along to consumers and taxpayers.